Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

315 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization.
Riaz A, Lewandowski RJ, Kulik L, Ryu RK, Mulcahy MF, Baker T, Gates V, Nayar R, Wang E, Miller FH, Sato KT, Omary RA, Abecassis M, Salem R. Riaz A, et al. Among authors: kulik l. Cardiovasc Intervent Radiol. 2010 Dec;33(6):1143-52. doi: 10.1007/s00270-009-9766-5. Epub 2009 Dec 5. Cardiovasc Intervent Radiol. 2010. PMID: 19967371 Free PMC article.
Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times.
Memon K, Kulik L, Lewandowski RJ, Wang E, Riaz A, Ryu RK, Sato KT, Marshall K, Gupta R, Nikolaidis P, Miller FH, Yaghmai V, Senthilnathan S, Baker T, Gates VL, Abecassis M, Benson AB 3rd, Mulcahy MF, Omary RA, Salem R. Memon K, et al. Among authors: kulik l. Gastroenterology. 2011 Aug;141(2):526-35, 535.e1-2. doi: 10.1053/j.gastro.2011.04.054. Epub 2011 Apr 30. Gastroenterology. 2011. PMID: 21664356 Free PMC article.
Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis.
Memon K, Kulik L, Lewandowski RJ, Wang E, Ryu RK, Riaz A, Nikolaidis P, Miller FH, Yaghmai V, Baker T, Abecassis M, Benson AB 3rd, Mulcahy MF, Omary RA, Salem R. Memon K, et al. Among authors: kulik l. J Hepatol. 2012 May;56(5):1112-1120. doi: 10.1016/j.jhep.2011.11.020. Epub 2012 Jan 13. J Hepatol. 2012. PMID: 22245905 Free PMC article.
Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progression.
Memon K, Kulik L, Lewandowski RJ, Mulcahy MF, Benson AB, Ganger D, Riaz A, Gupta R, Vouche M, Gates VL, Miller FH, Omary RA, Salem R. Memon K, et al. Among authors: kulik l. J Hepatol. 2013 Jan;58(1):73-80. doi: 10.1016/j.jhep.2012.09.003. Epub 2012 Sep 18. J Hepatol. 2013. PMID: 23000237 Free PMC article.
Prospective evaluation of patients with early-/intermediate-stage hepatocellular carcinoma with disease progression following arterial locoregional therapy: candidacy for systemic treatment or clinical trials.
Memon K, Kulik L, Lewandowski RJ, Gupta R, Ryu RK, Miller FH, Vouche M, Atassi R, Ganger D, Mulcahy MF, Salem R. Memon K, et al. Among authors: kulik l. J Vasc Interv Radiol. 2013 Aug;24(8):1189-1197.e2. doi: 10.1016/j.jvir.2012.12.025. Epub 2013 Mar 7. J Vasc Interv Radiol. 2013. PMID: 23474327
Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization.
Salem R, Gilbertsen M, Butt Z, Memon K, Vouche M, Hickey R, Baker T, Abecassis MM, Atassi R, Riaz A, Cella D, Burns JL, Ganger D, Benson AB 3rd, Mulcahy MF, Kulik L, Lewandowski R. Salem R, et al. Among authors: kulik l. Clin Gastroenterol Hepatol. 2013 Oct;11(10):1358-1365.e1. doi: 10.1016/j.cgh.2013.04.028. Epub 2013 May 2. Clin Gastroenterol Hepatol. 2013. PMID: 23644386
315 results